North America Defibrillators Market Development, Growth,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
34
North America Defibrillators Market Development, Growth, and Demand Forecast, 2013-2018 & 2023

Dublin, Feb. 06, 2019 (GLOBE NEWSWIRE) -- The "North America Defibrillators Market by Product, by End User, by Geography - Market Size, Share, Development, Growth, and Demand Forecast, 2013-2023" report has been added to ResearchAndMarkets.com's offering. The North American defibrillators market is expected to reach $8.1 billion by 2023, surging geriatric population, rising incidence of cardiac diseases, and growing demand for automated external defibrillators (AEDs) are some of the key factors driving the market growth. External defibrillators and implantable cardioverter defibrillators (ICDs) are the two products in the North American defibrillators market. The ICD category is further bifurcated into transvenous implantable cardioverter defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillators (S-ICDs). Among these two, T-ICD is expected to be the faster growing category in this market, advancing at a CAGR of 4.3% during the forecast period. In terms of volume, more than one million units of ICDs are expected to be sold by 2023. This can be attributed to the increasing incidence of sudden cardiac arrests (SCAs), development of technologically advanced ICDs, and growing adoption of S-ICDs and cardiac resynchronization therapy defibrillators (CRT-Ds). The report further classifies the North American T-ICDs market into CRT-Ds, dual-chamber ICDs, and single-chamber ICDs. The market for CRT-Ds is expected to generate $2.0 billion revenue by 2023, mainly on account of the increasing demand for CRT-Ds for the treatment of advanced heart failure. Among the various external defibrillators available in the North American defibrillators market, automated external defibrillator (AED) is expected to lead the market, in terms of size as well as growth, in the coming years. This category is expected to grow at the fastest CAGR of 5.9% during the forecast period. On the basis of end user, the North American defibrillators market is categorized into hospitals, clinics, and cardiac centers; public access settings; pre-hospital care settings; and home care settings. Public access settings as an end-user category is expected to observe fastest growth at a CAGR of 5.5% during the forecast period. Given the growing awareness about the life-saving potential of defibrillators in case of emergencies, the installation of these devices is increasing in public places such as train stations, schools and colleges, shopping centers, airports, malls, and leisure centers. These defibrillators are also known as public access defibrillators (PADs), as they can be used by anyone during an emergency. Several organizations in the U.S. are taking initiatives to install PADs in their vicinities. For example, in February 2016, the Sudden Cardiac Arrest Foundation, a national community-benefit organization in the U.S., granted funds to several schools for the procurement of AEDs through its You Can Save a Life at School AED Grant program. In terms of value, the Canadian defibrillators market is predicted to grow at a CAGR of 4.3% during the forecast period. Increasing government support in the form of funding and initiatives to increase awareness and provide training on defibrillation; presence of a large number of local suppliers; and rising number of SCA cases have boosted the demand for defibrillators in Canada in the last few years. Market Dynamics Trends

  • Growing focus on the installation of defibrillators in public places

Drivers

  • Advancements in the defibrillation technology
  • Surging geriatric population
  • Rising incidence of cardiac diseases
  • Growing demand for AEDs

Restraints

  • Product failures and recalls
  • Post-implantation complications associated with ICDs
  • Stringent regulatory norms

Opportunities

  • Rising demand for AEDs in pre-hospital settings
  • Awareness and training programs on defibrillation

Companies Mentioned

  • Koninklijke Philips N.V.
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Stryker Corporation
  • Medtronic plc
  • BIOTRONIK SE & Co. KG
  • SCHILLER AG
  • Asahi Kasei Corporation
  • Defibtech LLC
  • Cardiac Science Corporation

For more information about this report visit https://www.researchandmarkets.com/research/c...erica?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Cardiovascular Devices

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading

Top 5 Most Recently Viewed Articles

How a $100 Investment in Casey's General Stores Grew

Updated Category News Views 183

Understanding the Growth of Casey's General Stores Casey's General Stores (NASDAQ: CASY) has notably outperformed the market over the last decade. Investors have been delighted with an annualized return of approximately 16.93%, surpassing the market by 4.4%. A remarkable market capitalization of $19.79 billion reflects the company's robust position within the retail...

Continue Reading
THEON's 2024 Results Show Strong Growth and Future Potential

Updated Category News Views 394

THEON's Strong FY 2024 Performance Surpasses Expectations THEON International Plc, listed on Euronext Amsterdam as (THEON), has released its preliminary financial results for FY 2024, illustrating a remarkable performance throughout the year. With a solid strategy in place, the company not only met but exceeded its revenue guidance, showcasing its robust business model...

Continue Reading
Important Class Action Information for Ultra Clean Investors

Updated Category News Views 241

Essential Class Action Information for Investors In recent developments, Robbins LLP emphasizes the importance for stockholders of Ultra Clean Holdings, Inc. (NASDAQ: UCTT) who may have faced significant financial losses due to misleading company statements. The class action suits have been filed to protect investors who acquired securities within a specific time frame....

Continue Reading
Sable Resources Secures Additional $5 Million for Exploration

Updated Category News Views 206

Sable Resources Secures Additional $5 Million for Exploration VANCOUVER, British Columbia — Sable Resources Ltd. (TSXV:SAE | OTCQB:SBLRF) has officially announced a significant financial development. The company has received a $5 million payment from OR Royalties Inc. This payment is tied to the royalty agreement regarding TDG Gold Corp. which Sable sold to OR. This...

Continue Reading